Learn what drives our clients and us.
CLIENT AND
AGENCY NEWS
SHS acquires majority share in SIS-SCHWAGER Group
With its fourth fund, the medical technology investor SHS Gesellschaft für Beteiligungsmanagement from Tübingen has acquired a majority share in SIS Medical AG and SCHWAGER MEDICA AG [...]
Kidney rejection after transplantation: numares develops radically new urinalysis procedure
As part of its UMBRELLA study, numares HEALTH has discovered a urinalysis procedure for diagnosing the impending rejection of a transplanted kidney. By the end of 2016, [...]
TNI medical: more capital for innovative respiratory disease treatment
The SHS portfolio company TNI medical is receiving further funding in a second financing round. Two new investors - the Portuguese investment firm Pathena and a private [...]
numares expands range of lipid analysis products
Regensburg-based company numares has developed a new test system for use in diagnostic lipid analysis, the AXINON lipoFIT-S100-400. In early 2015, numares launched the AXINON lipoFIT-S100, its [...]
SHS acquires Novo Klinik-Service GmbH
With its fourth fund, the Tübingen based medical technology investor SHS Gesellschaft für Beteiligungsmanagement has acquired all shares of Novo Klinik-Service GmbH. The company is based in [...]
SHS invests in molecular diagnostics specialist GNA Biosolutions
The fund SHS IV has invested in GNA Biosolutions GmbH together with existing and new investors. GNA, a manufacturer of ultrafast pathogen diagnostic instruments, will receive fresh [...]